Navigation Links
Research and Markets - Global Antiviral Drugs Market to Grow at a CAGR of 9.48%, 2017-2021 with Bristol-Myers Squibb, F. Hoffmann-La Roche, Gilead Sciences & GlaxoSmithKline Leading the Market
Date:4/18/2017

DUBLIN, April 18, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Antiviral Drugs Market 2017-2021" report to their offering.

The global antiviral drugs market to grow at a CAGR of 9.48% during the period 2017-2021.

The report, Global Antiviral Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is technological advancements. The new hybridoma technique is a novel approach toward the development of monoclonal antibodies, which are selective in nature. This technique will not only have a positive impact against viral diseases but also decrease the cost of the overall treatment. It can be expected that antiviral agents, which were above $100 and could be used to control an epidemic effectively, can now be produced at 1% of its original cost.

According to the report, one of the major drivers for this market is stockpiling by public healthcare agencies. The CDC estimates that government organizations such as the WHO are also taking initiatives to secure public health during future outbreak of viral diseases by increasing the antiviral drugs stock. The CDC manages the Strategic National Stockpile, which includes storage of bulk quantities of antiviral medications for public health emergencies.

Key vendors

  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Gilead Sciences
  • GlaxoSmithKline

Other prominent vendors

  • AbbVie
  • Johnson & Johnson
  • Merck
  • Novartis

Key Topics Covered:

PART 01: Executive summary

PART 02: Research Methodology

PART 03: Introduction

PART 04: Disease Overview

PART 05: Market landscape

PART 06: Pipeline analysis

PART 07: Market segmentation by therapies

PART 08: Market segmentation by MOA

PART 09: Geographical segmentation

PART 10: Decision framework

PART 11: Drivers and challenges

PART 12: Market trends

PART 13: Competitive Landscape

PART 14: Key vendor analysis

PART 15: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/djspnx/global_antiviral

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-antiviral-drugs-market-to-grow-at-a-cagr-of-948-2017-2021-with-bristol-myers-squibb-f-hoffmann-la-roche-gilead-sciences--glaxosmithkline-leading-the-market-300440814.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Edgemont Capital Completes Sale Of Vince & Associates Clinical Research
3. Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
4. Sony Biotechnology Inc.s New Technology for Science Provides Researchers Results in Color
5. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
6. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
7. Lupus Research Institute Hosts First International Conference to Advance New Treatments for Lupus Nephritis
8. Clinical Team Researching the Impact of the EarlySense System Wins Best Novel Idea Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference
9. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
10. Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
11. Alzheimer Market: Drugs, Therapeutics & Diagnostics Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... , April 18, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a CAGR ... Global Arthroscopy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:4/18/2017)... Calif. , April 18, 2017  Socionext ... of collaboration started in 2016, in which Socionext ... Brain SOINN". The companies achieved initial results in ... solution by Artificial Brain SOINN. The results will ... Big Sight, April 19-21, at booths 4505 & ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... 2017 , ... NEPC Director Kevin Welner has been awarded ... The award honors scholars exemplary in their capacity to communicate important education research ... the capacity to deepen the public’s understanding and appreciation of the value of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Today, Bright Pink , a national non-profit organization focusing ... a new CEO. , Bright Pink is proud to announce Katie Thiede as their ... to a new role as Chairman of the Board and launched a national search ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed king of the ... Juicer, and the George Foreman Grill (which sold more than 100 million units worldwide), ... 25 years. , Now, due to changes in the broadcast media landscape, the once ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health and ... to track their cognitive health, and share results with their physicians. Members and guests ... the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):